Skip to main content
. 2022 Jul 18;24:51. doi: 10.1186/s13058-022-01542-y

Fig. 6.

Fig. 6

Tumorigenic capacity of Dusp4NULL Trp53Δ MYCAMP cells is associated with chromosome 5 amplification. A Whole-genome sequencing of PMEC-derived cell lines with Dusp4 loss, Trp53 loss, and/or MYC amplification. Dusp4NULL Trp53Δex7 MYCAMP cells (tumor forming) or Dusp4FLOX Trp53Δex7 MYCAMP cells (not tumor forming). B FISH for chromosome 5 centromeric amplicon in DPM tumors compared to normal murine mammary gland tissue. C Representative images of FISH in metaphase spreads from DPM and Dusp4FLOX cells. In the right panel is a magnification of chromosome 5